HCP Live (2024)
In contrast, preoperative GLP-2 plasma concentrations did not differ, but increased 3.4-fold within the first postoperative day in patients with PHLF, compared to an 1.5-times increase in patients who did not develop PHLF, resulting in 2.0-times higher GLP-2 level in PHLF on POD1 ( p = 0.008)
Survodutide (BI 456906) is another promising dual GLP-1R/GCGR agonist under development for the treatment of T2D, obesity, and NASH
M., Thuren, T., Zalewski, A
Black, green, blue and red curves indicate corrected, unmasked, masked, and phase-randomized maps, respectively
Most Popular Beyond weight loss Metabolic problems like blood sugar dysregulation can return after stopping a GLP-1, Biermann says